Literature DB >> 20606326

Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.

Akihito Muto1, Lynn Model, Kenneth Ziegler, Sammy D D Eghbalieh, Alan Dardik.   

Abstract

For patients with coronary artery disease or limb ischemia, placement of a vein graft as a conduit for a bypass is an important and generally durable strategy among the options for arterial reconstructive surgery. Vein grafts adapt to the arterial environment, and the limited formation of intimal hyperplasia in the vein graft wall is thought to be an important component of successful vein graft adaptation. However, it is also known that abnormal, or uncontrolled, adaptation may lead to abnormal vessel wall remodeling with excessive neointimal hyperplasia, and ultimately vein graft failure and clinical complications. Therefore, understanding the venous-specific pathophysiological and molecular mechanisms of vein graft adaptation are important for clinical vein graft management. Of particular importance, it is currently unknown whether there exist several specific distinct molecular differences in the venous mechanisms of adaptation that are distinct from arterial post-injury responses; in particular, the participation of the venous determinant Eph-B4 and the vascular protective molecule Nogo-B may be involved in mechanisms of vessel remodeling specific to the vein. This review describes (1) venous biology from embryonic development to the mature quiescent state, (2) sequential pathologies of vein graft neointima formation, and (3) novel candidates for strategies of vein graft management. Scientific inquiry into venous-specific adaptation mechanisms will ultimately provide improvements in vein graft clinical outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20606326      PMCID: PMC3662001          DOI: 10.1253/circj.cj-10-0495

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  123 in total

1.  Follow-up of valves in saphenous vein bypass grafts with duplex ultrasonography.

Authors:  B R Vesti; J Primozich; R O Bergelin; E Strandness
Journal:  J Vasc Surg       Date:  2001-02       Impact factor: 4.268

Review 2.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

Review 3.  Transcription factor decoys for the prevention of vein bypass graft failure.

Authors:  Michael J Mann; Michael S Conte
Journal:  Am J Cardiovasc Drugs       Date:  2003       Impact factor: 3.571

4.  A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening.

Authors:  Jamie Y Jeremy; Richard Bulbulia; Jason L Johnson; Patricia Gadsdon; Vikram Vijayan; Nilima Shukla; Frank C T Smith; Gianni D Angelini
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

5.  Inhibition of carotis venous bypass graft disease by intraoperative nucleic acid-based therapy in rabbits.

Authors:  B Kusch; S Waldhans; A Sattler; A Wagner; M Hecker; R Moosdorf; S Vogt
Journal:  Thorac Cardiovasc Surg       Date:  2006-09       Impact factor: 1.827

6.  Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.

Authors:  Dai Yamanouchi; Hiroshi Banno; Masanori Nakayama; Masayuki Sugimoto; Hiromine Fujita; Masayoshi Kobayashi; Hiroyuki Kuwano; Kimihiro Komori
Journal:  J Vasc Surg       Date:  2005-10       Impact factor: 4.268

7.  Accelerated arteriosclerosis of vein grafts in inducible NO synthase(-/-) mice is related to decreased endothelial progenitor cell repair.

Authors:  Ursula Mayr; Yiping Zou; Zhongyi Zhang; Hermann Dietrich; Yanhua Hu; Qingbo Xu
Journal:  Circ Res       Date:  2005-12-29       Impact factor: 17.367

8.  Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells.

Authors:  E Bretschneider; M Braun; A Fischer; M Wittpoth; E Glusa; K Schrör
Journal:  Thromb Haemost       Date:  2000-09       Impact factor: 5.249

9.  Naringenin inhibits neointimal hyperplasia following arterial reconstruction with interpositional vein graft.

Authors:  Cenk Cayci; Trevor C Wahlquist; Serin I Seckin; Vefa Ozcan; Ayse B Tekinay; Timothy P Martens; Mehmet C Oz; Jeffrey A Ascherman
Journal:  Ann Plast Surg       Date:  2010-01       Impact factor: 1.539

10.  Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases.

Authors:  Florence Gizard; Dennis Bruemmer
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more
  51 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

Review 2.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

3.  γ-Secretase inhibitor DAPT attenuates intimal hyperplasia of vein grafts by inhibition of Notch1 signaling.

Authors:  Yong Guang Xiao; Wei Wang; Dan Gong; Zhi Fu Mao
Journal:  Lab Invest       Date:  2014-04-21       Impact factor: 5.662

4.  Procedure for human saphenous veins ex vivo perfusion and external reinforcement.

Authors:  Alban Longchamp; Florent Allagnat; Xavier Berard; Florian Alonso; Jacques-Antoine Haefliger; Sébastien Deglise; Jean-Marc Corpataux
Journal:  J Vis Exp       Date:  2014-10-01       Impact factor: 1.355

5.  Neointimal hyperplasia in allogeneic and autologous venous grafts is not different in nature.

Authors:  Albert Busch; Elena Hartmann; Nicole Wagner; Süleyman Ergün; Ralph Kickuth; Richard Kellersmann; Udo Lorenz
Journal:  Histochem Cell Biol       Date:  2015-03-19       Impact factor: 4.304

6.  Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.

Authors:  Bian Wu; Evan C Werlin; Mian Chen; Giorgio Mottola; Anuran Chatterjee; Kevin D Lance; Daniel A Bernards; Brian E Sansbury; Matthew Spite; Tejal A Desai; Michael S Conte
Journal:  J Vasc Surg       Date:  2018-07-29       Impact factor: 4.268

Review 7.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

Review 8.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

Review 9.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

Review 10.  Challenges and novel therapies for vascular access in haemodialysis.

Authors:  Jeffrey H Lawson; Laura E Niklason; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.